Pharmicell
COMPANYSTEM CELL THERAPYPRODUCTSSERVICENEWSCONTACT
  • English
  • German formal - Sie
RNL Bio takes over the majority holding’s of Pharmicell Europe
25 January 2011 - Sunghee Cho, Managing Director of Pharmicell Europe GmbH announced that she had sold her 99.5% shareholding in Pharmicell Europe GmbH to RNL Bio Co. Ltd..
Read more...
 
Pharmicell to Bring Stem Cell Therapy to European Market

Berlin, November 3, 2008 — Pharmicell received the official authorization for production of somatic cell therapeutics derived from adipose tissue. The license allows to produce and to market adipose tissue derived stem cells in Europe.

Read more...
 
Breast augmentation with own fat and stem cells from adipose tissue

This weekend the Cellport Clinic in Yokohama hosted visitors from Berlin. Dr. Andreas Kurtz, CEO of Pharmicell and Dr. Olaf Kauder, plastic surgeon from Berlin visited the state of the art clinic now providing a revolutionary treatment for breast.

Read more...
 
Company launch in Berlin-Brandenburg
Biotech company opens high-end adult stem cell production facility for the development of regenerative therapies at Europarc Dreilinden.
Read more...